| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sakeer K et al. | Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. | 2010 Jul-Aug | Pharm Dev Technol | pmid:19772376 |
| Pinto Reis C et al. | Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. | 2016 | Pharm Dev Technol | pmid:25567611 |
| Wu J and Partridge LD | Dissociated dopaminergic neurons from substantia nigra zona compacta in young rats lack functional NMDA receptors. | 1998 | Pflugers Arch. | pmid:9479023 |
| Thodis E et al. | Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. | 1998 Nov-Dec | Perit Dial Int | pmid:9932656 |
| Williams PF et al. | No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. | 2000 May-Jun | Perit Dial Int | pmid:10898060 |
| Lye WC | Nystatin prophylaxis for fungal peritonitis: to be or not to be? | 2007 Sep-Oct | Perit Dial Int | pmid:17704437 |
| Wong PN et al. | Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. | 2007 Sep-Oct | Perit Dial Int | pmid:17704443 |
| Robitaille P et al. | Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. | 1995 | Perit Dial Int | pmid:7734569 |
| Lo WK and Cheng IK | Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD? | 1999 Mar-Apr | Perit Dial Int | pmid:10357198 |
| Faix RG et al. | Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. | 1989 | Pediatrics | pmid:2909957 |